Cargando…

Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment

Squamous cell carcinoma of the prostate is rare and represents 0.5% to 1% of prostatic carcinomas. Transformation of prostatic adenocarcinoma into squamous cell carcinoma after LH-RH agonist intake has been reported in only 8 cases in the literature. To our knowledge, our case is the second pure squ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ichaoui, Hamza, Nasr, Sonia Ben, Gargouri, Faten, Zribi, Aref, Hermi, Amine, Fendri, Sana, Balti, Mehdi, Ayari, Jihen, Khiari, Ramzi, Msakni, Issam, Mansouri, Nada, Ghozzi, Samir, Haddaoui, Abderrazek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The African Field Epidemiology Network 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906544/ https://www.ncbi.nlm.nih.gov/pubmed/33708294 http://dx.doi.org/10.11604/pamj.2019.34.125.19421

Ejemplares similares

Urothelial bladder carcinoma in childhood: a case report
por: Zribi, Aref, et al.
Publicado: (2020)

Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population
por: Zribi, Aref, et al.
Publicado: (2020)

Clival chordoma in a young male patient: a case report
por: Zribi, Aref, et al.
Publicado: (2020)

Functional Bladder Paraganglioma Treated by Partial Cystectomy
por: Hermi, Amine, et al.
Publicado: (2019)

Idiopathic scrotal calcinosis: A new case report
por: Hedhli, Houcem, et al.
Publicado: (2020)

An unusual and severe case of paclitaxel‐induced hand‐foot syndrome
por: Ben Abdallah, Ichrak, et al.
Publicado: (2020)

Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer
por: Szabó, Zsuzsanna, et al.
Publicado: (2021)

Percutaneous Nephrolithotomy (PCNL): Standard Technique Versus Tubeless - 125 Procedures
por: Ichaoui, Hamza, et al.
Publicado: (2019)

Paratesticular Angiomyofibroblastoma-Like Tumor: Unusual Case of a Solidocystic Form
por: Msakni, Issam, et al.
Publicado: (2017)

Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma
por: Treszl, Andrea, et al.
Publicado: (2013)

Multiple unusual urological locations of hydatic cysts including kidney, retrovesical and spermatic cord. A new case report
por: Hermi, A., et al.
Publicado: (2019)

Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes
por: He, Yingna, et al.
Publicado: (2010)

Synthesis of Radiolabeled Technetium- and Rhenium-Luteinizing Hormone-Releasing Hormone ((99m)Tc/Re-Acdien-LHRH) Conjugates for Targeted Detection of Breast Cancer Cells Overexpressing the LHRH Receptor
por: Calderon, Lindsay E., et al.
Publicado: (2021)

The Predictive Value of 2D Myocardial Strain for Epirubicin-Induced Cardiotoxicity
por: Ben Abdallah, Ichrak, et al.
Publicado: (2020)

Enhanced Anti-Tumoral Activity of Methotrexate-Human Serum Albumin Conjugated Nanoparticles by Targeting with Luteinizing Hormone-Releasing Hormone (LHRH) Peptide
por: Taheri, Azade, et al.
Publicado: (2011)

Nonrandomized Comparison of Efficacy and Side Effects of Bicalutamide Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Analogs in Combination With Radiation Therapy in the CHHiP Trial
por: Tree, Alison, et al.
Publicado: (2022)

A Paratesticular Angiolipoma: A Case Report of a Rare Benign Scrotal Mass and Review of Literature
por: Nouioui, Mohamed Ali, et al.
Publicado: (2019)

A rare highly aggressive tumor of the kidney: The pure epithelioid angiomyolipoma
por: Bani, Mohamed Amine, et al.
Publicado: (2018)

Contemporary hormone therapy with LHRH agonists for prostate cancer: avoiding osteoporosis and fracture
por: Wilson, Hannah C.P., et al.
Publicado: (2015)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
por: Liu, Nana, et al.
Publicado: (2012)

Characterization of Luteinizing Hormone and Luteinizing Hormone Receptor and Their Indispensable Role in the Ovulatory Process of the Medaka
por: Ogiwara, Katsueki, et al.
Publicado: (2013)

Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levels
por: Popovics, Petra, et al.
Publicado: (2014)

Response of the corpus luteum to luteinizing hormone.
por: Niswender, G D
Publicado: (1981)

Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone.
por: Philip, P. A., et al.
Publicado: (1993)

Luteinizing Hormone-Releasing Hormone Distribution in the Anterior Hypothalamus of the Female Rats
por: Castañeyra-Ruiz, Leandro, et al.
Publicado: (2013)

The utilization of basal luteinizing hormone in combination with the basal luteinizing hormone and follicle-stimulating hormone ratio as a diagnostic tool for central precocious puberty in girls
por: Chotipakornkul, Nuntika, et al.
Publicado: (2023)

Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome
por: Chun, Sungwook
Publicado: (2014)

Luteinizing hormone and its dilemma in ovulation induction
por: Kumar, Pratap, et al.
Publicado: (2011)

Ganirelix and the prevention of premature luteinizing hormone surges
por: Mannaerts, Bernadette
Publicado: (2023)

Do basal Luteinizing Hormone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio Have Significance in Prognosticating the Outcome of In vitro Fertilization Cycles in Polycystic Ovary Syndrome?
por: Singh, Neeta, et al.
Publicado: (2021)

Do Basal Luteinizing Hormone and Luteinizing Hormone/ Follicle-Stimulating Hormone Ratio have Significance in Prognosticating the Outcome of In vitro Fertilization Cycles in Polycystic Ovary Syndrome?
por: Neeta, Singh, et al.
Publicado: (2021)

Do Basal Luteinizing Hormone and Luteinizing Hormone/Follicle- Stimulating Hormone Ratio have Significance in Prognosticating the Outcome of In vitro Fertilization Cycles in Polycystic Ovary Syndrome?
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Luteinizing hormone beta gene polymorphism and its effect on semen quality traits and luteinizing hormone concentrations in Murrah buffalo bulls
por: Reen, Jagish Kour, et al.
Publicado: (2018)

Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists
por: Spicer, Darcy V, et al.
Publicado: (2000)

The Roles of Luteinizing Hormone, Follicle-Stimulating Hormone and Testosterone in Spermatogenesis and Folliculogenesis Revisited
por: Oduwole, Olayiwola O., et al.
Publicado: (2021)

The crystal structure of the β subunit of luteinizing hormone and a model for the intact hormone
por: Larson, Steven B., et al.
Publicado: (2019)

Topographical localization of the receptors for luteinizing hormone- releasing hormone on the surface of dissociated pituitary cells
Publicado: (1977)

Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls?
por: Lee, Dong Seong, et al.
Publicado: (2013)

Effects of growth hormone administration on luteinizing hormone secretion in healthy older men and women
por: Muniyappa, Ranganath, et al.
Publicado: (2017)

Effect of follicle-stimulating hormone and luteinizing hormone levels on egg-laying frequency in hens
por: Prastiya, Ragil Angga, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r6gj7chluggm8jc4lssgsb3g7q